<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35436248</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1526-7598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>134</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Anesthesia and analgesia</Title>
          <ISOAbbreviation>Anesth Analg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inactivation of Prefrontal Cortex Attenuates Behavioral Arousal Induced by Stimulation of Basal Forebrain During Sevoflurane Anesthesia.</ArticleTitle>
        <Pagination>
          <StartPage>1140</StartPage>
          <EndPage>1152</EndPage>
          <MedlinePgn>1140-1152</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006011</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cholinergic stimulation of prefrontal cortex (PFC) can reverse anesthesia. Conversely, inactivation of PFC can delay emergence from anesthesia. PFC receives cholinergic projections from basal forebrain, which contains wake-promoting neurons. However, the role of basal forebrain cholinergic neurons in arousal from the anesthetized state requires refinement, and it is currently unknown whether the arousal-promoting effect of basal forebrain is mediated through PFC. To address these gaps in knowledge, we implemented a novel approach to the use of chemogenetic stimulation and tested the role of basal forebrain cholinergic neurons in behavioral arousal during sevoflurane anesthesia. Next, we investigated the effect of tetrodotoxin-mediated inactivation of PFC on behavioral arousal produced by electrical stimulation of basal forebrain during sevoflurane anesthesia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Adult male and female transgenic rats (Long-Evans-Tg [ChAT-Cre]5.1 Deis; n = 22) were surgically prepared for expression of excitatory hM3D(Gq) receptors or mCherry in basal forebrain cholinergic neurons, and activation of these neurons by local delivery of compound 21, an agonist for hM3D(Gq) receptors. The transgenic rats were fitted with microdialysis probes for agonist delivery into basal forebrain and simultaneous prefrontal acetylcholine measurement. Adult male and female Sprague Dawley rats were surgically prepared for bilateral electrical stimulation of basal forebrain and tetrodotoxin infusion (156 μM and 500 nL) into PFC (n = 9) or bilateral electrical stimulation of piriform cortex (n = 9) as an anatomical control. All rats were implanted with electrodes to monitor the electroencephalogram. Heart and respiration rates were monitored using noninvasive sensors. A 6-point scale was used to score behavioral arousal (0 = no arousal and 5 = return of righting reflex).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compound 21 delivery into basal forebrain of rats with hM3D(Gq) receptors during sevoflurane anesthesia produced increases in arousal score (P &lt; .001; confidence interval [CI], 1.80-4.35), heart rate (P &lt; .001; CI, 36.19-85.32), respiration rate (P &lt; .001; CI, 22.81-58.78), theta/delta ratio (P = .008; CI, 0.028-0.16), and prefrontal acetylcholine (P &lt; .001; CI, 1.73-7.46). Electrical stimulation of basal forebrain also produced increases in arousal score (P &lt; .001; CI, 1.85-4.08), heart rate (P = .018; CI, 9.38-98.04), respiration rate (P &lt; .001; CI, 24.15-53.82), and theta/delta ratio (P = .020; CI, 0.019-0.22), which were attenuated by tetrodotoxin-mediated inactivation of PFC.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study validates the role of basal forebrain cholinergic neurons in behavioral arousal and demonstrates that the arousal-promoting effects of basal forebrain are mediated in part through PFC.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Anesthesia Research Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dean</LastName>
            <ForeName>Jon G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular and Integrative Physiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Consciousness Science.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fields</LastName>
            <ForeName>Christopher W</ForeName>
            <Initials>CW</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brito</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Consciousness Science.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silverstein</LastName>
            <ForeName>Brian H</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Consciousness Science.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rybicki-Kler</LastName>
            <ForeName>Chloe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fryzel</LastName>
            <ForeName>Anna M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Groenhout</LastName>
            <ForeName>Trent</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Tiecheng</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mashour</LastName>
            <ForeName>George A</ForeName>
            <Initials>GA</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Consciousness Science.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pal</LastName>
            <ForeName>Dinesh</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>From the Departments of Anesthesiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Molecular and Integrative Physiology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Consciousness Science.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 GM111293</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Anesth Analg</MedlineTA>
        <NlmUniqueID>1310650</NlmUniqueID>
        <ISSNLinking>0003-2999</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018678">Cholinergic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013876">Thiophenes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>38LVP0K73A</RegistryNumber>
          <NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>4368-28-9</RegistryNumber>
          <NameOfSubstance UI="D013779">Tetrodotoxin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N9YNS0M02X</RegistryNumber>
          <NameOfSubstance UI="D000109">Acetylcholine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>RC2V4W0EYC</RegistryNumber>
          <NameOfSubstance UI="C000711730">compound 21</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>doi: 10.1213/ANE.0000000000006049</RefSource>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000109" MajorTopicYN="N">Acetylcholine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001143" MajorTopicYN="N">Arousal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066187" MajorTopicYN="Y">Basal Forebrain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018678" MajorTopicYN="N">Cholinergic Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020318" MajorTopicYN="N">Rats, Long-Evans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013779" MajorTopicYN="N">Tetrodotoxin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013876" MajorTopicYN="N">Thiophenes</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>17</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35436248</ArticleId>
        <ArticleId IdType="pmc">PMC9093733</ArticleId>
        <ArticleId IdType="doi">10.1213/ANE.0000000000006011</ArticleId>
        <ArticleId IdType="pii">00000539-202206000-00005</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Pal D, Dean JG, Liu T, et al. . Differential role of prefrontal and parietal cortices in controlling level of consciousness.
Curr Biol. 2018;28:2145–2152.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6039257</ArticleId>
            <ArticleId IdType="pubmed">29937348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkar A, Fedrigon DC, Alam F, Vanini G, Mashour GA, Pal D. Carbachol and nicotine in prefrontal cortex have differential effects on sleep-wake states.
Front Neurosci. 2020;14:567849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7714754</ArticleId>
            <ArticleId IdType="pubmed">33328847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huels ER, Groenhout T, Fields CW, Liu T, Mashour GA, Pal D. Inactivation of prefrontal cortex delays emergence from sevoflurane anesthesia.
Front Syst Neurosci. 2021;15:690717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8299111</ArticleId>
            <ArticleId IdType="pubmed">34305541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celesia GG, Jasper HH. Acetylcholine released from cerebral cortex in relation to state of activation.
Neurology. 1966;16:1053–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5950916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marrosu F, Portas C, Mascia MS, et al. . Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats.
Brain Res. 1995;671:329–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7743225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kikuchi T, Wang Y, Sato K, Okumura F. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats.
Br J Anaesth. 1998;80:644–648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9691870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shichino T, Murakawa M, Adachi T, Arai T, Miyazaki Y, Mori K. Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo.
Br J Anaesth. 1998;80:365–370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9623440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lapierre JL, Kosenko PO, Lyamin OI, Kodama T, Mukhametov LM, Siegel JM. Cortical acetylcholine release is lateralized during asymmetrical slow-wave sleep in northern fur seals.
J Neurosci. 2007;27:11999–12006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6673386</ArticleId>
            <ArticleId IdType="pubmed">17978041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control.
Anesthesiology. 2005;103:1268–1295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16306742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pal D, Silverstein BH, Lee H, Mashour GA. Neural correlates of wakefulness, sleep, and general anesthesia: an experimental study in rat.
Anesthesiology. 2016;125:929–942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5069172</ArticleId>
            <ArticleId IdType="pubmed">27617688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung LS, Chu L, Prado MAM, Prado VF. Forebrain acetylcholine modulates isoflurane and ketamine anesthesia in adult mice.
Anesthesiology. 2021;134:588–606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33635947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briand LA, Gritton H, Howe WM, Young DA, Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex.
Prog Neurobiol. 2007;83:69–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2080765</ArticleId>
            <ArticleId IdType="pubmed">17681661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henny P, Jones BE. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons.
Eur J Neurosci. 2008;27:654–670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2426826</ArticleId>
            <ArticleId IdType="pubmed">18279318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zant JC, Kim T, Prokai L, et al. . Cholinergic neurons in the basal forebrain promote wakefulness by actions on neighboring non-cholinergic neurons: an opto-dialysis study.
J Neurosci. 2016;36:2057–2067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4748083</ArticleId>
            <ArticleId IdType="pubmed">26865627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee MG, Hassani OK, Alonso A, Jones BE. Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep.
J Neurosci. 2005;25:4365–4369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6725118</ArticleId>
            <ArticleId IdType="pubmed">15858062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han Y, Shi YF, Xi W, et al. . Selective activation of cholinergic basal forebrain neurons induces immediate sleep-wake transitions.
Curr Biol. 2014;24:693–698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24613308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu M, Chung S, Zhang S, et al. . Basal forebrain circuit for sleep-wake control.
Nat Neurosci. 2015;18:1641–1647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5776144</ArticleId>
            <ArticleId IdType="pubmed">26457552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo TY, Cai S, Qin ZX, et al. . Basal forebrain cholinergic activity modulates isoflurane and propofol anesthesia.
Front Neurosci. 2020;14:559077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7652994</ArticleId>
            <ArticleId IdType="pubmed">33192246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Zhang W, Wu Y, et al. . Cholinergic-induced specific oscillations in the medial prefrontal cortex to reverse propofol anesthesia.
Front Neurosci. 2021;15:664410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8187623</ArticleId>
            <ArticleId IdType="pubmed">34121993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witten IB, Steinberg EE, Lee SY, et al. . Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement.
Neuron. 2011;72:721–733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3282061</ArticleId>
            <ArticleId IdType="pubmed">22153370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Choo H, Huang XP, et al. . The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.
ACS Chem Neurosci. 2015;6:476–484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4368042</ArticleId>
            <ArticleId IdType="pubmed">25587888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson KJ, Khajehali E, Bradley SJ, et al. . DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo.
ACS Pharmacol Transl Sci. 2018;1:61–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6407913</ArticleId>
            <ArticleId IdType="pubmed">30868140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jendryka M, Palchaudhuri M, Ursu D, et al. . Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
Sci Rep. 2019;9:4522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6418145</ArticleId>
            <ArticleId IdType="pubmed">30872749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goutaudier R, Coizet V, Carcenac C, Carnicella S. Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats.
PLoS One. 2020;15:e0238156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7500623</ArticleId>
            <ArticleId IdType="pubmed">32946510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muindi F, Kenny JD, Taylor NE, et al. . Electrical stimulation of the parabrachial nucleus induces reanimation from isoflurane general anesthesia.
Behav Brain Res. 2016;306:20–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26971629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solt K, Van Dort CJ, Chemali JJ, Taylor NE, Kenny JD, Brown EN. Electrical stimulation of the ventral tegmental area induces reanimation from general anesthesia.
Anesthesiology. 2014;121:311–319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4112744</ArticleId>
            <ArticleId IdType="pubmed">24398816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanford LD, Yang L, Liu X, Tang X. Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity.
Brain Res. 2006;1084:80–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16546144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang X, Yang L, Liu X, Sanford LD. Influence of tetrodotoxin inactivation of the central nucleus of the amygdala on sleep and arousal.
Sleep. 2005;28:923–930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16218075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 6th ed. Academic Press; 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>Gao S, Proekt A, Renier N, Calderon DP, Pfaff DW. Activating an anterior nucleus gigantocellularis subpopulation triggers emergence from pharmacologically induced coma in rodents.
Nat Commun. 2019;10:2897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6603023</ArticleId>
            <ArticleId IdType="pubmed">31263107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alkire MT, McReynolds JR, Hahn EL, Trivedi AN. Thalamic microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat.
Anesthesiology. 2007;107:264–272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17667571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pal D, Mallick BN. GABA in pedunculopontine tegmentum increases rapid eye movement sleep in freely moving rats: possible role of GABA-ergic inputs from substantia nigra pars reticulata.
Neuroscience. 2009;164:404–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19698764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gui H, Liu C, He H, Zhang J, Chen H, Zhang Y. Dopaminergic projections from the ventral tegmental area to the nucleus accumbens modulate sevoflurane anesthesia in mice.
Front Cell Neurosci. 2021;15:671473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8119636</ArticleId>
            <ArticleId IdType="pubmed">33994950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor NE, Chemali JJ, Brown EN, Solt K. Activation of D1 dopamine receptors induces emergence from isoflurane general anesthesia.
Anesthesiology. 2013;118:30–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3527840</ArticleId>
            <ArticleId IdType="pubmed">23221866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo T, Yu S, Cai S, et al. . Parabrachial neurons promote behavior and electroencephalographic arousal from general anesthesia.
Front Mol Neurosci. 2018;11:420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6288364</ArticleId>
            <ArticleId IdType="pubmed">30564094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang D, Guo Y, Li H, et al. . Selective optogenetic activation of orexinergic terminals in the basal forebrain and locus coeruleus promotes emergence from isoflurane anaesthesia in rats.
Br J Anaesth. 2021;126:279–292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33131759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang LN, Yang C, Ouyang PR, et al. . Orexin-A facilitates emergence of the rat from isoflurane anesthesia via mediation of the basal forebrain.
Neuropeptides. 2016;58:7–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26919917</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
